Markets:

Overview

News

Currencies

International

Treasuries

Quest Diagnostics (NY:DGX)

177.38 -0.76 (-0.43%)

Streaming Delayed Price Updated: 1:11 PM EST, Jan 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Quest Diagnostics

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Quest Diagnostics Inc (DGX) Q3 2021 Earnings Call Transcript ↗

October 21, 2021

DGX earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Quest Diagnostics: Q3 Earnings Insights ↗

October 21, 2021

Quest Diagnostics (NYSE:DGX) reported its Q3 earnings results on Thursday, October 21, 2021 at 06:45 AM. Here's what investors need to know about the announcement....

Via Benzinga

Supporting Employees' Emotional Health During the Pandemic

October 21, 2021

SOURCE: Quest Diagnostics

Via 3BL Media

Quest Raises FY21 Outlook Again On Strong COVID-19 Volumes In Q3 ↗

October 21, 2021

Quest Diagnostics Incorporated (NYSE: DGX) has posted a better-than-expected Q3 adjusted EPS of $3.96, down 7.9% Y/Y, beating the consensus estimate of $2.87. Sales...

Via Benzinga

The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO ↗

October 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus CDC Committee Recommends Approval Of Merck, Pfizer's Pneumococcal Vaccine...

Via Benzinga

Give it a Shot: The Latest on the Flu & COVID Vaccine

October 13, 2021

SOURCE: Quest Diagnostics

Via 3BL Media

Earnings Scheduled For October 21, 2021 ↗

October 21, 2021

Companies Reporting Before The Bell • Tri Pointe Homes (NYSE:TPH) is estimated to report quarterly earnings at $0.89 per share on revenue of $946.97 million. •...

Via Benzinga

Earnings Outlook For Quest Diagnostics ↗

October 20, 2021

Quest Diagnostics (NYSE:DGX) is set to give its latest quarterly earnings report on Thursday, 2021-10-21. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

Price Over Earnings Overview: Quest Diagnostics ↗

October 19, 2021

Right now, Quest Diagnostics Inc. (NYSE:DGX) share price is at $145.77, after a 1.43% gain. Moreover, over the past month, the stock fell by 5.60%, but in the past...

Via Benzinga

Communities of Color Hit Hardest by COVID-19 and Lack Trust in Healthcare

October 18, 2021

SOURCE: Quest Diagnostics

Via 3BL Media

The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs ↗

October 18, 2021

Biotech stocks rebounded in the week ended Oct. 15, bouncing from third straight weekly losses. The strength came amid a broader market rally and some sector-specific news....

Via Benzinga

DA Authorizes Quest Diagnostics' COVID-19 Collection Materials for Emergency Use

October 15, 2021

SOURCE: Quest Diagnostics

Via 3BL Media

Reducing Health Inequities While Expanding the Pipeline to Create a More Diverse Health Care Workforce

October 08, 2021

SOURCE: Quest Diagnostics

Via 3BL Media

Addressing the Healthcare Needs of Underserved Communities

October 07, 2021

SOURCE: Quest Diagnostics

Via 3BL Media

Overview Of Value Stocks In The Healthcare Sector ↗

October 04, 2021

What is a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...

Via Benzinga

Over Half of U.S. Children Have Detectable Levels of Lead in Their Blood, Finds Quest Diagnostics Health Trends® Study Published in JAMA Pediatrics

September 30, 2021

SOURCE: Quest Diagnostics

Via 3BL Media

Topics Energy

The Delta Variant Has Made Quest Diagnostics Indispensable ↗

September 29, 2021

On the back of steady demand for COVID-19 testing, Quest Diagnostics bumped up its guidance for this year.

Via The Motley Fool

Big Changes Coming to Covid Testing in Response to Rising Demand Under Latest Mandates

September 28, 2021

Via FinancialNewsMedia

Engaging Student Journalists to Promote Health Awareness

September 28, 2021

SOURCE: Quest Diagnostics

Via 3BL Media

Black and Hispanic Communities Are Lagging in Getting Vaccinated. How These Organizations Are Trying to Change That

September 23, 2021

SOURCE: Quest Diagnostics

Via 3BL Media

Topics Death

Learn More About Quest’s Commitment to Patients, Clients, Employees and Communities by Reading the Company’s Annual Corporate Responsibility Report

September 21, 2021

SOURCE: Quest Diagnostics

Via 3BL Media

Instead of Buying Dogecoin, Invest in These 3 Companies That Are Bullish on Blockchain Technology ↗

September 16, 2021

These businesses have exposure to blockchain technology and they're safer options than buying crypto directly.

Via The Motley Fool

Why New Covid-19 Test Supplies Will Be Needed Soon in Wake of US President’s New OSHA Mandates

September 14, 2021

Via FinancialNewsMedia

The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test ↗

September 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (...

Via Benzinga

Quest Diagnostics Updates 2021 Outlook On Surging Demand Of COVID-19 Tests ↗

September 09, 2021

Since Quest Diagnostics Incorporated (NYSE: DGX) reported its Q2 FY21 financial results, COVID-19 molecular testing volumes were stronger than anticipated through the...

Via Benzinga

The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization ↗

September 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:...

Via Benzinga

Underwhelming: Tepid Jobs Data Could Add New Variable To Fed Policy Equation ↗

September 03, 2021

That hissing noise you hear is the air being let out of the market’s tires after an epically disappointing August jobs report. The Delta variant seems to be sinking its...

Via Benzinga

Topics Economy

The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod ↗

September 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc...

Via Benzinga

The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself ↗

September 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:...

Via Benzinga

The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab ↗

September 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV...

Via Benzinga

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.